Nevertheless, the lack of good results may perhaps indicate that our current understanding of molecular disease etiologies and drug mechanisms of motion hasn't retained tempo Using the technological advancements in genomics.seventy five70 The BATTLE Section II medical demo prolonged this observation by endeavoring to match qualified therapies based